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Introduction {#sec1}
============

A DNA double-strand break (DSB) is the most genotoxic type of DNA lesion. If misrepaired or left unrepaired, DSBs can lead to carcinogenesis and cell death. DSBs are repaired by two major repair pathways: homology-directed repair (HDR) and non-homologous end joining (NHEJ) ([@bib60]). HDR is active only in the S/G~2~ phases, whereas NHEJ functions throughout the cell cycle ([@bib54]) ([@bib14]) ([@bib58]) ([@bib79]). Note that NHEJ plays the dominant role in the G~0~/G~1~ phases and repairs approximately 80% of ionizing-radiation (IR)-induced DSBs even in the S/G~2~ phases ([@bib9]) ([@bib78]). NHEJ is initiated by the binding of a KU70/KU80 heterodimer and a DNA-PK-dependent protein kinase catalytic subunit (DNA-PKcs) to the DSB ends and finishes with ligation by a complex involving DNA LIGASE 4 (LIG4) and XRCC4 ([@bib14]) ([@bib26]). Ligation by LIG4 requires 3′-OH and 5′-phosphate DSB ends, termed "clean" DSBs ([@bib70]) ([@bib15]). Thus, direct ligation by NHEJ requires the prior removal of blocking adducts and the restoration of ligatable (clean) DSB ends.

DSBs induced by endogenous and exogenous sources are generally accompanied by chemical adducts at DSB ends and are termed "dirty" DSBs ([@bib5]) ([@bib89]). A typical exogenous source, IR, generates such dirty DSBs bearing multiple DNA lesions, including abasic sites and damaged bases at DSB ends ([@bib19]) ([@bib75]) ([@bib6]) ([@bib40]) ([@bib52]). Dirty DSBs are also produced by an anti-cancer Topoisomerase II (TOP2) poison, etoposide, which stabilizes the covalent association of TOP2 adducts at the 5′ ends of DSBs, referred to as a pathological TOP2 cleavage complex (TOP2cc) and also TOP2-DNA adducts ([@bib65]). Since chemical modifications as well as 5′ TOP2 adducts obstruct direct ligation of ends by LIG4, these blocking adducts need to be removed prior to ligation by NHEJ. Removal of such blocking modifications from DSBs is the rate-limiting step in DSB repair. This is evidenced by data showing that the vast majority of restriction-enzyme (RE) (*Asi*SI)-induced ligatable clean DSBs are repaired within an hour ([@bib13]), whereas it takes several hours for DSB-repair pathways to ligate the majority of dirty DSBs induced by IR and etoposide ([@bib33], [@bib90]). However, the molecular mechanisms underlying the removal of the blocking adducts remains poorly understood, in part owing to the complexity of blocking adducts present at IR-induced DSBs.

MRE11 forms a complex with RAD50 and NBS1 (Xrs2 in *Saccharomyces cerevisiae*), and the resulting MRN(X) complex is involved in the initial DSB resection step of HDR, which generates 3′ single-stranded tails at DSBs ([@bib78]) ([@bib71]) ([@bib51], [@bib96]) ([@bib28]) (reviewed in [@bib61], [@bib63]). Yeast genetic studies suggest an important role for MRE11 endonuclease in the repair of DSBs with dirty ends as evidenced by the following study. Although *Saccharomyces cerevisiae* mutants expressing nuclease-deficient MRE11 perform HDR of RE-induced clean DSBs with nearly normal kinetics, the mutant is extremely sensitive to IR ([@bib61]) ([@bib53]) ([@bib88]), suggesting that MRE11 plays an important role in DSB repair other than DSB resection, potentially by removing blocking adducts. This is supported by data showing that the nuclease activity of *Schizosaccharomyces pombe* MRE11 removes both 3′ TOP1 and 5′ TOP2 adducts from DSBs *in vivo* ([@bib31]). Moreover, the nuclease activity of purified MRN complex is capable of removing both 3′ and 5′ blocking adducts from DSBs ([@bib12]) ([@bib21]) ([@bib22]) (reviewed in ([@bib63])). Although the role of yeast MRE11 in creating ligatable ends has been established by comparing the repair kinetics of IR-induced dirty DSBs with those of RE-induced clean DSBs ([@bib47], [@bib88]), similar studies have not yet been performed in mammalian cells, because human cells deficient in MRE11 nuclease activity display severe genome instability and are inviable ([@bib33]).

The removal of blocking TOP2 adducts provides an excellent way to examine the molecular mechanism by which dirty DSBs are processed and clean DSBs are restored for the following reasons. Pulse exposure to etoposide specifically generates DSBs bearing a well-characterized blocking adduct, a pathological TOP2cc, and its number can be accurately measured ([@bib33]). TOP2 normally resolves DNA catenanes by transiently forming a DSB, a TOP2cc in duplex DNA, which allows the intact DNA duplex to pass through the DSB, followed by religation of the DSB by TOP2 ([@bib18]) ([@bib59]). The repair of etoposide-induced DSBs is performed by NHEJ as well as by HDR ([@bib33]) ([@bib4]). Repair by NHEJ requires prior removal of 5′ TOP2 adducts by tyrosyl-DNA-phosphodiesterase 2 (TDP2) and MRE11 ([@bib33]) ([@bib45]) ([@bib46]). MRE11 contributes to the removal of 5′ TOP2 adducts to a considerably greater extent than does TDP2, as MRE11 nuclease-deficient cells, but not *TDP2*^−/−^ cells, display an endogenous accumulation of pathological TOP2ccs, which leads to cell death ([@bib33]). In HDR, MRE11 nuclease activity is tightly controlled by the ubiquitination and phosphorylation pathways during DSB resection in the S/G~2~ phases ([@bib38]) ([@bib25]) ([@bib17]) ([@bib27]) ([@bib42]). It remains unclear exactly how MRE11 nuclease is activated at pathological TOP2ccs during the G~1~ phase.

The E3 ligase RNF168 catalyzes H2A K15 monoubiquitination and K63-linked polyubiquitination near DSB sites ([@bib44]) ([@bib35]) ([@bib82]) ([@bib24]) ([@bib50]) ([@bib85]). UBC13 plays a crucial role in K63-linked polyubiquitination ([@bib82]) ([@bib50]) ([@bib95]). RAP80 is a reader of K63-linked ubiquitin chains and facilitates the recruitment of the BRCA1-A complex onto DSB sites ([@bib74]) ([@bib87]) ([@bib43]) ([@bib81]) ([@bib34]). The induction of DSBs leads to the formation of a complex between BRCA1 and MRE11 at DSB sites in a UBC13-dependent manner and promotes DSB resection ([@bib95]) ([@bib29]) ([@bib16]). RNF168 and BRCA1 play a redundant role in promoting HDR ([@bib97]). It remains unclear whether UBC13-dependent K63 ubiquitin signaling also contributes to DSB repair during the G~1~ phase (reviewed in [@bib55], [@bib85]). Although NHEJ is required for both V(D)J recombination of antigen receptor genes and development of B and T lymphocytes ([@bib1]), V(D)J recombination is not impaired by the loss of MRE11, RAP80, RNF168, or UBC13, indicating that all four are dispensable for NHEJ of clean DSBs carrying 3′-OH and 5′-phosphate moieties ([@bib91]) ([@bib11]) ([@bib93]) ([@bib23]).

To date, no bioassay has accurately assessed the capability of NHEJ except analysis of V(D)J recombination. Previous studies have evaluated the efficiency of NHEJ by measuring the repair kinetics of IR-induced DSBs as well as IR sensitivity in the G~1~ phase. However, these phenotypic assays do not distinguish NHEJ from the preceding step, which involves the processing of dirty DSBs to restore clean ends. Another widely used phenotypic analysis of NHEJ measures the repair of I-*Sce*1 RE-induced DSBs in reporter genes (reviewed in [@bib39]). However, this assay does not assess the frequency of the accurate DSB-repair events that restore the I-*Sce*1 site, even though the vast majority of the NHEJ events are accurate ([@bib8]). Here we describe a new assay for assessing the capability of NHEJ. To this end, we expressed a regulatable *Asi*SI RE coupled to the estrogen receptor (ER-*Asi*SI) in cells ([@bib13]) ([@bib7]); pulse-exposed the cells to an estrogen antagonist, 4-hydroxytamoxifen (4-OHT), to transiently activate *Asi*SI; and measured the number of unrepaired DSBs during the G~1~ phase. We verified over a 100-fold delay in DSB repair in the absence of LIG4. We, therefore, conclude that our repair kinetics analysis of ER-*Asi*SI-induced DSBs may measure virtually all NHEJ events in *wild-type* cells.

We show that UBC13 promotes the recruitment of MRE11 nuclease to remove 5′ TOP2 adducts from pathological TOP2ccs for subsequent NHEJ. We tested the involvement of UBC13 and MRE11 nuclease activity in the repair of IR-induced DSBs in the G~1~ phase. Although both these factors are essential for the efficient repair of dirty DSBs generated by etoposide and IR, they are both dispensable for the repair of *Asi*SI-induced clean DSBs. These results indicate that the UBC13 promotes MRE11-dependent removal of blocking adducts from IR-induced dirty DSBs in addition of that of TOP2 adducts prior to their ligation by NHEJ. We propose that K63-linked ubiquitin signaling involving MRE11 is indicated as the key step to determine the repair kinetics of dirty DSBs.

Results {#sec2}
=======

UBC13 Contributes to DSB Repair during the G~1~ Phase {#sec2.1}
-----------------------------------------------------

We exposed an asynchronous population of MCF-7 human breast cancer cells to etoposide for 30 min, then counted the number of conjugated-ubiquitin FK2 foci, which represent various types of ubiquitin chains ([@bib77]). [Table S1](#mmc2){ref-type="supplementary-material"} shows the list of mutant cells analyzed in this study. We detected FK2 foci colocalizing with 53BP1 foci in virtually all cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We also detected etoposide-induced FK2 foci in serum-starved G~1~ cells ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We depleted UBC13 with shRNA (shUBC13) in the serum-starved cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and found an \~80% decrease in the number of etoposide-induced FK2 foci ([Figures 1](#fig1){ref-type="fig"}A, [S1](#mmc1){ref-type="supplementary-material"}A, and S1D). Since UBC13 promotes K63-linked polyubiquitination at DSB sites ([@bib82]), this result indicates that a majority of the FK2 foci contain K63-linked polyubiquitination. We found that UBC13 depletion impaired H2AX ubiquitination in G~1~ phase, suggesting that H2AX is one of the targets of UBC13 ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Thus, UBC13 generates K63-linked polyubiquitin chains of the substrates, including H2A/H2AX, at DSB sites in the G~1~ as well as in the S/G~2~ phases.Figure 1UBC13 Contributes to DSB Repair by Recruiting BRCA1 and RAP80 onto DSB Sites during the G~1~ Phase(A) Average number of etoposide-induced FK2 foci in MCF-7 cells synchronized during the G~1~ phase by serum starvation (24 h). We examined *wild-type* MCF-7 cells treated with shRNA targeting UBC13 (shUBC13) and non-targeting shRNA (shControl). Synchronized cells were treated with etoposide (10 μM) for 30 min, washed, and incubated with etoposide-free media. Error bars show the standard deviation (SD) from three independent experiments. At least 50 G~1~-phase (cyclin A-negative) cells per experiment were counted. Single asterisk indicates p = 1.1 × 10^−3^, calculated by Student\'s t test. Representative images and box plots of FK2 foci are shown in [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1D, respectively.(B) DSB-repair kinetics of G~1~-phase MCF-7 cells after pulse exposure (0--0.5 h) to etoposide (10 μM). Average number of γH2AX foci was counted at 0.5 and 8.5 h after addition of etoposide. Data are as shown in (A). Single, double, and triple asterisks indicate p = 1.2 × 10^−3^, p = 5.6 × 10^−4^, and p = 3.2 × 10^−5^, respectively, calculated by Student\'s t test. The box plots of γH2AX foci are shown in [Figure S1](#mmc1){ref-type="supplementary-material"}F.(C and D) Average number of etoposide-induced BRCA1 (C) and RAP80 (D) foci per cell. The experimental procedure and data are as shown in (A). Asterisks indicate p = 9.3 × 10^−4^ in (C) and p = 8.0 × 10^−3^ in (D). Representative images and box plots of BRCA1 and RAP80 foci are shown in [Figures S1](#mmc1){ref-type="supplementary-material"}I and S1J, respectively.

To confirm the role of UBC13 in DSB repair in the G~1~ phase, we exposed serum-starved MCF-7 cells to etoposide for 30 min, then monitored the resolution kinetics of the γH2AX foci ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}F). Pulse exposure (0.5 h) to etoposide caused similar increases in the number of γH2AX foci in all cell types tested. At 8 h after removal of etoposide, the number of γH2AX foci had diminished almost to background levels in the control cells but persisted in the *DNA-PKcs*^−/−^ mutant cells ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}F--S1H). The delay in DSB repair in the shUBC13 cells was also more prominent than in the control cells. These results suggest that UBC13 contributes to DSB repair through a pathway other than HDR. We next assessed the possible functional interaction between UBC13 and canonical NHEJ by depleting UBC13 in *DNA-PKcs*^−/−^ cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and examining the etoposide-induced γH2AX foci. The depletion of UBC13 did not affect the repair kinetics of *DNA-PKcs*^−/−^ cells ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}F). Since UBC13 is dispensable for efficient NHEJ ([@bib91]), it is surprising that UBC13 shows a phenotype similar to DNA-PKcs deficiency for the repair of TOP2cc lesions caused by etoposide. Moreover, this epistatic relationship between UBC13 and NHEJ suggests that UBC13 contributes to NHEJ-mediated repair of these lesions.

UBC13-Dependent Focus Formation of BRCA1 and RAP80 in G~1~ Cells {#sec2.2}
----------------------------------------------------------------

UBC13-dependent ubiquitination promotes the recruitment of various factors, including BRCA1 and RAP80, to DSB sites in the S/G~2~ phases (reviewed in [@bib55], [@bib85]). We asked whether the formation of BRCA1 and RAP80 foci could also occur in the G~1~ phase. Pulse exposure (0.5 h) to etoposide caused 2.9- and 2.4-fold increases in the number of BRCA1 and RAP80 foci, respectively, in serum-starved *wild-type* MCF-7 cells ([Figures 1](#fig1){ref-type="fig"}C, 1D, [S1](#mmc1){ref-type="supplementary-material"}I, and S1J). UBC13 depletion reduced the numbers of BRCA1 foci and RAP80 foci by 5 and 1.5 folds, respectively, in G~1~ cells. Additionally, the truncated form of RAP80 lacking ubiquitin-interacting motifs (RAP80-UIMΔ), which specifically recognize K63-linked polyubiquitin chains of H2A/H2AX ([Figures S1](#mmc1){ref-type="supplementary-material"}K and S1L) ([@bib50], [@bib74]), completely abolished the ability to form foci after etoposide treatment in G~1~ phase. These results indicate that, similar to what has been observed during the S/G~2~ phases ([@bib86]), UBC13-dependent K63-linked ubiquitination plays a pivotal role in the recruitment of BRCA1 and RAP80 onto DSB sites during the G~1~ phase.

RAP80 and BRCA1 Contribute to DSB Repair during G~1~ Phase {#sec2.3}
----------------------------------------------------------

To test the role of RAP80 in DSB repair in the G~1~ phase, we generated *RAP80*^*−/−*^ cells by disrupting exon 5 of *RAP80* in TK6 human B cells and in MCF-7 cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). NHEJ is preferred over HDR to repair etoposide-induced DSBs ([@bib49]). The *RAP80*^*−/−*^ cells showed a higher sensitivity to etoposide than did the *wild-type* cells ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). To analyze the role of RAP80 in DSB repair in the G~1~ phase, we enriched G~1~-phase MCF-7 cells by serum starvation, exposed the cells to etoposide for 30 min, then monitored the resolution kinetics of the γH2AX foci ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}E). Remarkably, the NHEJ-deficient *DNA-PKcs*^−/−^ and the *RAP80*^*−/−*^ MCF-7 cells exhibited a very similar phenotype: a strong defect in the repair of etoposide-induced DSBs ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}E). Thus, RAP80 plays an important role in NHEJ-dependent repair of etoposide-induced DSBs in the G~1~ phase. Since RAP80 is dispensable for NHEJ of clean DSBs ([@bib93]), our results suggest that RAP80 is involved in the repair of DSBs with TOP2 adducts, similar to BRCA1 ([@bib73]).Figure 2RAP80 and BRCA1 Contribute to DSB Repair during the G~1~ Phase(A) Analysis of DSB-repair kinetics (as presented in [Figure 1](#fig1){ref-type="fig"}B). Single and double asterisks indicate p = 1.3 × 10^−4^ and p = 3.8 × 10^−4^, respectively. Representative images and box plots of γH2AX foci are shown in [Figure S2](#mmc1){ref-type="supplementary-material"}E.(B) Average number of etoposide-induced BRCA1 foci in *wild-type* and *RAP80*^*−/−*^ MCF-7 cells before and after pulse exposure (0.5 h) to etoposide. Standard deviation (SD) was calculated from three independent experiments. Asterisk indicates p = 4.3 × 10^−5^. Representative images and box plots of BRCA1 foci are shown in [Figure S2](#mmc1){ref-type="supplementary-material"}F.(C) DSB-repair kinetics of MCF-7 cells in the G~1~ phase following pulse exposure (0.5 h) to etoposide (10 μM). Experimental procedure and data presentation are as shown in [Figure 1](#fig1){ref-type="fig"}B. Single and double asterisks indicate p = 6.5 × 10^−3^ and p = 3.2 × 10^−5^, respectively. Representative images and box plots of γH2AX foci are shown in [Figure S2](#mmc1){ref-type="supplementary-material"}H.

We next investigated the impact of *RAP80* disruption on BRCA1-focus formation at etoposide-induced DSB sites in serum-starved G~1~ MCF-7 cells. The loss of RAP80 caused a 20-fold decrease in the number of etoposide-induced BRCA1 foci ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}F), indicating that RAP80 is required for the recruitment of BRCA1 onto DSB sites in the G~1~ phase. We previously showed that BRCA1 plays an important role in the removal of 5′ TOP2 adducts from pathological TOP2ccs in the G~1~ phase ([@bib73]). In agreement with this, shRNA-mediated depletion of BRCA1 ([Figure S2](#mmc1){ref-type="supplementary-material"}G) delayed the repair kinetics of etoposide-induced DSBs in *wild-type* cells to a level very similar to that found in *DNA-PKcs*^*−/−*^ cells ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}H). The depletion did not further delay repair kinetics in *DNA-PKcs*^−/−^ cells ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}H). Thus, both UBC13 and RAP80 play a crucial role in the NHEJ-mediated repair of etoposide-induced DSBs, most likely by recruiting BRCA1 onto DSB sites and promoting the removal of 5′ TOP2 adducts from DSBs.

UBC13, RAP80, and BRCA1 Promote the Removal of Etoposide-Induced TOP2 Adducts Independent of TDP2 {#sec2.4}
-------------------------------------------------------------------------------------------------

We measured the number of TOP2ccs in the G~1~ phase by analyzing serum-starved MCF-7 cells. We lysed cells and separated TOP2cc from free TOP2 in cellular lysates by subjecting them to sedimentation by means of cesium chloride (CsCl) density-gradient ultra-centrifugation, as described previously ([@bib33]). TOP2ccs were detected as single or double dots in the middle fractions of the TOP2-DNA complex, shown at the bottom of the blot in [Figure S3](#mmc1){ref-type="supplementary-material"}A. As demonstrated previously, we detected a greater number of etoposide-induced TOP2ccs in both nuclease-deficient *MRE11*^*-/H129N*^ and BRCA1-depleted TK6 cells, compared with *wild-type* cells ([@bib33]) ([@bib73]) ([Figures 3](#fig3){ref-type="fig"}A, [S3](#mmc1){ref-type="supplementary-material"}B, and S3E). To identify the role played by UBC13 in removing etoposide-induced TOP2ccs, we depleted UBC13 in serum-starved MCF-7 cells and subjected these cells to the same assay. The MCF-7 cells also showed a greater number of TOP2ccs ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}F) compared with shControl cells. UBC13-depleted cells reconstituted with *wild-type* UBC13 (shUBC13-WT) did not accumulate etoposide-induced TOP2ccs, whereas expression of catalytically inactive UBC13 C87A mutant protein (shUBC13-C87A) resulted in accumulation of TOP2ccs compared with that of shUBC13 cells ([Figures 3](#fig3){ref-type="fig"}B, [S3](#mmc1){ref-type="supplementary-material"}D, and S3F). These results indicate that E2 ubiquitin-conjugating activity of UBC13 is required for the efficient removal of 5′ TOP2 adducts. Likewise, *RAP80*^*−/−*^ cells and *RAP80*^*−/−*^ cells expressing RAP80-UIMΔ caused an increase in the number of TOP2ccs in serum-starved MCF-7 cells ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}G). We therefore conclude that ubiquitin signaling pathway involving BRCA1, RAP80, and UBC13 is required for efficient removal of 5′ TOP2 adducts from etoposide-induced TOP2ccs.Figure 3UBC13, RAP80, and BRCA1 Promote the Removal of Etoposide-Induced TOP2 Adducts Independent of TDP2(A) Quantification of TOP2-DNA-cleavage-complexes (TOP2ccs) in TK6 lymphoid cells carrying the indicated genotypes relative to the amount of TOP2ccs in *wild-type* cells. Schematic of *in vivo* TOP2cc measurement by immunodetection with α-TOP2 antibody is shown in [Figure S3](#mmc1){ref-type="supplementary-material"}A. Cells were treated with etoposide (10 μM) ("+") or DMSO ("-") for 2 h. *BRCA1*^*AID/AID*^ cells were pretreated with auxin for 2 h, then incubated with etoposide (10 μM) plus auxin for an additional 2 h. *MRE11*^*+/H129N*^ cells were treated with 4-hydroxytamoxifen (4-OHT) for 3 days to inactivate the *wild-type* MRE11 allele, then treated with etoposide (10μM) for 2 h. Error bars represent standard deviation (SD) of three independent experiments. Asterisk indicates p = 2.8 × 10^−2^, calculated by Student\'s t test. Representative images of dot plots are shown in [Figure S3](#mmc1){ref-type="supplementary-material"}E.(B) Quantification of TOP2ccs in MCF-7 cells with the indicated genotypes relative to the amount of TOP2ccs in *wild-type* MCF-7 cells. Cells were incubated with serum-free medium for 24 h then treated with etoposide for 2 h. Each experiment was performed independently at least three times. Error bars represent SD. Single, double, triple, and quadruple asterisks indicate p = 4.7 × 10^−4^, p = 6.4 × 10^−3^, p = 5.3 × 10^−3^, and p = 1.9 × 10^−2^ respectively, calculated by Student\'s t -test. Representative images of dot plots are shown in [Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G.

Since TDP2 is implicated in removal of TOP2ccs ([@bib45]) we tested if UBC13 and RAP80 facilitate the removal of 5′ TOP2 adducts in a manner dependent on TDP2. To this end, we depleted UBC13 and BRCA1 in *TDP2*^*−/−*^ MCF-7 cells and generated *RAP80*^*−/−*^*/TDP2*^*−/−*^ MCF-7 cells ([Figures S1](#mmc1){ref-type="supplementary-material"}C, [S2](#mmc1){ref-type="supplementary-material"}B, and S2G), then measured the number of TOP2ccs in the G~1~ phase. Consistent with earlier reports ([@bib33]) ([@bib45]), depletion of TDP2 caused an increase in TOP2ccs upon etoposide treatment ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}F). UBC13-depletion, *RAP80*^*−/−*^ mutation, and BRCA1-depletion further enhanced the accumulation of etoposide-induced TOP2ccs in *TDP2*^*−/−*^ cells ([Figures 3](#fig3){ref-type="fig"}B, [S3](#mmc1){ref-type="supplementary-material"}F, and S3G). Thus, like BRCA1, UBC13 and RAP80 promote the removal of 5′ TOP2 adducts in a TDP2-independent manner in the G~1~ phase.

To examine the genetic interaction between MRE11 and UBC13, we depleted UBC13 in *MRE11*^*-/H129N*^ cells (shUBC13/*MRE11*^*-/H129N*^) and analyzed etoposide-induced TOP2ccs. The accumulation of TOP2ccs in shUBC13/*MRE11*^*-/H129N*^ cells is very similar to those of *MRE11*^*-/H129N*^ cells ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}E). This epistatic relationship suggests that UBC13-dependent ubiquitination pathway promotes the removal of TOP2ccs through MRE11 nuclease activity.

Ubiquitin Signaling Involving UBC13, RAP80, and BRCA1 Is Required for Efficient Recruitment of MRE11 Nuclease onto DSB Sites in G~1~ Cells {#sec2.5}
------------------------------------------------------------------------------------------------------------------------------------------

We investigated the role played by UBC13-dependent ubiquitin signaling in the recruitment of MRE11 to DSB sites. To this end, we examined MRE11 foci following exposure of G~1~-phase MCF-7 cells to etoposide. These treatments caused increases in the number of MRE11 foci colocalizing with 53BP1, a marker of DSB sites ([Figure S4](#mmc1){ref-type="supplementary-material"}). MRE11-focus formation was impaired in BRCA1-depleted cells after etoposide treatment, as shown previously ([@bib73]) ([Figure 4](#fig4){ref-type="fig"}A). The depletion of UBC13 reduced the percentage of MRE11-positive cells by \~60% upon treatment with etoposide ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}). Similarly, *RAP80*^*−/−*^ cells showed an \~70% reduction in the percentage of MRE11-positive cells upon treatment with etoposide. These results indicate that in ubiquitin signaling involving UBC13, RAP80, and BRCA1, all three facilitate the recruitment of MRE11 onto DSB sites for the efficient removal of the adducts of dirty DSBs.Figure 4UBC13-Mediated Ubiquitin Signaling Involving UBC13, RAP80, and BRCA1 is Required for Efficient Recruitment of MRE11 Nuclease onto DSB Sites in G~1~ Cells(A) Quantification of MRE11-positive MCF-7 cells with at least 10 foci per nucleus for the indicated genotypes. Serum-starved MCF-7 cells were treated with etoposide (10 μM) for 30 min. Error bars were plotted for standard deviation (SD) from three independent experiments. Single, double, and triple asterisks indicate p = 2.3 × 10^−4^, p = 5.3 × 10^−5^, and p = 1.3 × 10^−4^, respectively, calculated by Student\'s t test. Representative images of etoposide-induced MRE11/53BP1 foci are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}.(B) Etoposide-induced complex formation of BRCA1 and MRE11 in G~1~-phase MCF-7 cells. Whole-cell extracts (WCEs) were prepared from the indicated cells, untreated ("-") or treated ("+") with etoposide (10 μM) for 0.5 h. "Input" indicates 5% of WCEs used for immunoprecipitation. BRCA1 was immunoprecipitated from the WCEs. Intensities of the immunoprecipitated MRE11 bands for the indicated genotypes were normalized to those of the input. The graph indicates relative band intensities of the MRE11 bands in comparison with the untreated *wild-type* (Lane 1). Single and double asterisks indicate p = 2.1 × 10^−2^ and p = 1.5 × 10^−3^, respectively, calculated by Student\'s t test.

UBC13 Is Essential for DNA-Damage-Induced Stable Complex Formation between BRCA1 and MRE11 in the G~1~ Phase {#sec2.6}
------------------------------------------------------------------------------------------------------------

Upon DNA damage in the S/G~2~ phases, BRCA1 physically interacted with the MRN complex ([@bib29], [@bib64]) in a UBC13-dependent manner ([@bib95]), which promotes DSB resection by MRE11. This finding prompted us to analyze DNA-damage-induced complex formation between BRCA1 and MRE11, specifically in G~1~-phase cells. We exposed serum-starved MCF-7 cells to etoposide for 30 min, immunoprecipitated BRCA1, and tested for the presence of co-immunoprecipitated MRE11 by western blotting. No interactions between BRCA1 and MRE11 were seen in the absence of etoposide, whereas etoposide exposure induced interactions (lanes 2 and 4 of [Figure 4](#fig4){ref-type="fig"}B). Remarkably, the depletion of UBC13 abolished the DNA-damage-induced interaction (lane 6 of [Figure 4](#fig4){ref-type="fig"}B). RAP80 deletion also decreased the amount of MRE11 associating with BRCA1 (lane 10 of [Figure 4](#fig4){ref-type="fig"}B). These results indicate that, upon DNA damage in the G~1~ phase, UBC13 and RAP80 facilitate a stable interaction between BRCA1 and MRE11. These data support the notion that UBC13-mediated ubiquitin signaling activates the nuclease activity of MRE11 via interaction with BRCA1 at DSB sites. Considering the vital role played by UBC13, RAP80, and BRCA1 in NHEJ-dependent repair of etoposide-induced DSBs ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}A, and 2C), these data suggest that UBC13-mediated ubiquitin signaling promotes the removal of 5′ TOP2 adducts by activating MRE11.

The Loss of LIG4 Reduces Repair of RE-Induced Clean DSBs over 100-Fold in the G~1~ Phase {#sec2.7}
----------------------------------------------------------------------------------------

The I-*Sce*1 reporter assays currently used to measure NHEJ events do not correctly measure the capability of NHEJ, because the I-*Sce*1 RE can re-cleave the accurately repaired junction, introducing a bias in favor of inaccurate repair that deletes the I-*Sce*1 site ([@bib8]). We thus sought to establish a method to measure the frequency of all NHEJ events correctly. To this end, we expressed ER-*Asi*SI RE in TK6 cells and introduced clean DSBs via pulse exposure (4 h) of cells to 4-OHT ([@bib36]). The 4-OHT treatment caused an increase by over eight times in the number of γH2AX foci in all genotypes (0 h in [Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). The number of γH2AX foci did not decrease from 0 to 1 h after 4-OHT removal owing to residual cleavage activity of ER-*Asi*SI RE. From 1 to 2 h, the number of γH2AX foci had dropped almost to background levels in the *wild-type* cells ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A), which agrees with the previous finding that *Asi*SI-induced DSBs are repaired within an hour ([@bib13]). In contrast, even at 4 h after 4-OHT removal, essentially all γH2AX foci persisted in the *LIG4*^−/−^ cells, indicating that the *Asi*SI-induced DSBs are repaired through the NHEJ pathway. The data indicated over 100-fold delay in DSB repair in the absence of LIG4 ([Figure 5](#fig5){ref-type="fig"}A), which is in sharp contrast with only up to several folds decrease in the number of (inaccurate) NHEJ events measured by reporter genes carrying the I-*Sce*1 site in NHEJ-deficient cells in comparison with *wild-type* cells ([@bib10], [@bib20], [@bib30], [@bib75], [@bib94]).Figure 5MRE11 Nuclease and UBC13-Mediated Ubiquitin Signaling Are Required for Efficient Repair of IR-Induced Dirty DSBs in the G~1~ Phase(A) Repair rate of DSBs induced by *Asi*SI restriction enzyme in G~1~-phase TK6 cells. Cells expressing *Asi*SI fused with estrogen receptor (ER) were treated with 4-OHT for 4 h for DSB induction. We analyzed γH2AX foci in cyclin A-negative cells after 4-OHT was removed (time 0 h). We subtracted the average number of foci in the 4-OHT-untreated cells from the average number of foci in the 4-OHT-treated cells. Values correspond to the percentage of unrepaired DSBs relative to the value at time 0 h, set to 100%. Error bars were plotted for standard deviation (SD) from three independent experiments. More than 50 G~1~ cells (cyclin A negative) were analyzed for each experiment. Single, double, and triple asterisks indicate p = 1.9 × 10^−5^, p = 2.9 × 10^−5^, and p = 4.3 × 10^−5^, respectively, calculated by Student\'s t test. Box plots of γH2AX foci at the indicated time points (0, 1, 2, and 4 h) are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}A.(B--E) Repair rate of DSBs induced by IR (1 Gy) in G~1~-phase TK6 and HCT116 cells. Average number of γH2AX foci in cyclin A-negative cells was counted at the indicated time points. We subtracted the average number of foci in IR-untreated cells from the average number of foci in IR-treated cells. Values correspond to the percentage of unrepaired DSBs relative to the value at time 0.3 h, set to 100%. Error bars were plotted for standard deviation (SD) from three independent experiments. In (B), p values were 2.0 × 10^−4^ (shUBC13 versus *wild-type*), 2.1 × 10^−3^ (shBRCA1 versus *wild-type*), 1.9 × 10^−5^ (*MRE11*^*-/H129N*^ versus *wild-type*), 9.5 × 10^−5^ (*LIG4*^−/−^/*MRE11*^*-/H129N*^ versus *wild-type*), 4.1 × 10^−4^ (*EXD2*^*−/−*^ versus *wild-type*), 3.6 × 10^−2^ (*ARTEMIS*^*−/−*^ versus *wild-type*), 6.3 × 10^−6^ (*EXO1*^*−/−*^ versus *wild-type*), and 1.7× 10^−4^ (shUBC13/*MRE11*^*-/H129N*^ versus *wild-type*), calculated by Student\'s t test. Box plots of γH2AX foci at the indicated time points (0, 0.3, and 6 h) are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}D. In (C), asterisks indicate p = 1.3 × 10^−4^ (single) and p = 7.9 × 10^−5^ (double), calculated by Student\'s t test. Box plots of γH2AX foci at the indicated time points (0, 0.3, and 6 h) are shown in [Figure S6](#mmc1){ref-type="supplementary-material"}D. In (D), asterisks indicate p = 5.1× 10^−4^ (single) and p = 3.8 × 10^−2^ (double), calculated by Student\'s t test. Box plots of γH2AX foci at the indicated time points (0, 0.3, and 6 h) are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}F. In (E), asterisks indicate p = 1.2× 10^−2^ (single) and p = 3.2 × 10^−3^ (double), calculated by Student\'s t test. Box plots of γH2AX foci at the indicated time points (0, 0.3, and 6 h) are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}H.

MRE11 Nuclease and UBC13-Dependent Ubiquitin Signaling Are Dispensable for NHEJ but Required for Efficient Repair of IR-Induced DSBs {#sec2.8}
------------------------------------------------------------------------------------------------------------------------------------

Similar to *wild-type* cells, at 2 h after 4-OHT removal, the number of γH2AX foci per cell had declined to near background levels in UBC13-depleted ([Figure S5](#mmc1){ref-type="supplementary-material"}B), BRCA1-depleted ([Figure S5](#mmc1){ref-type="supplementary-material"}C), and MRE11 nuclease-deficient cells ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). Thus, UBC13, BRCA1, and the nuclease activity of MRE11 are all dispensable for NHEJ. In contrast to *Asi*SI-mediated DSBs, IR-induced foci require a longer time (6 h) to drop back to background levels in *wild-type* cells ([Figure 5](#fig5){ref-type="fig"}B). The repair was NHEJ dependent as seen by the persistence of foci in *LIG4*^*−/−*^ cells ([Figure 5](#fig5){ref-type="fig"}B). Interestingly, UBC13-depleted and *MRE11*^*-/H129N*^ cells also showed the persistence of foci, approximately 54% and 69% of that in *LIG4*^*−/−*^ mutant cells, respectively, at 6 h after IR exposure ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). These values are probably an under-estimation of the actual contributions of UBC13 and MRE11 to the NHEJ of IR-induced DSBs since there were some residual UBC13 and MRE11 proteins left in their depleted cells. *LIG4*^*−/−*^/*MRE11*^*-/H129N*^ mutant cells ([Figure S5](#mmc1){ref-type="supplementary-material"}E) did not show an increase in γH2AX foci compared with *LIG4*^*−/−*^ mutant cells ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). Thus, MRE11 nuclease activity collaborates with NHEJ-dependent repair, most likely by removing blocking adducts prior to NHEJ of clean DSBs. We conclude that MRE11 and UBC13 play a dominant role in the removal of blocking adducts from DSB ends preceding canonical NHEJ.

Although a previous study using shRNA to knockdown MRE11 reported nearly normal repair of IR-induced DSBs in MRE11-depleted cells ([@bib10]), we found a very severe defect in IR-induced DSB repair in MRE11 nuclease-deficient TK6 cells ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). We thus tested the effect of MRE11 depletion on the repair of IR-induced DSBs in another cell line: HCT116 cells. To achieve a sufficient depletion of MRE11, we inserted auxin-induced-degron (AID) tag sequences into the endogenous *MRE11* allelic genes, generating *MRE11*^*AID/AID*^ HCT116 cells ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). When we depleted MRE11 using shRNA alone in HCT116 cells ([Figure S6](#mmc1){ref-type="supplementary-material"}C), the depletion had very little effect on the repair of IR-induced DSBs during the G~1~ phase ([Figures 5](#fig5){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}D), as shown previously ([@bib10]). In marked contrast, cells simultaneously treated with auxin and shRNA showed delayed repair kinetics very similar to that of HCT116 cells treated with an inhibitor of DNA-PKcs to inhibit NHEJ ([Figures 5](#fig5){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}D). The present results indicate that shRNA-mediated depletion of MRE11 might not be sufficient to identify the critical role of MRE11 in DSB repair. This observation of HCT116 cells is reminiscent of previous data indicating that a mere \~1% of the endogenous MRE11 protein is sufficient to effectively prevent the prominent phenotype, an accumulation of spontaneously arising mitotic chromosome breaks in TK6 cells ([@bib32]). We conclude that MRE11 is required for the removal of blocking adducts from IR-induced DSBs for subsequent NHEJ.

RNF8, RNF168, and BRCA1 Contribute to Cellular Tolerance to IR {#sec2.9}
--------------------------------------------------------------

Although BRCA1-depleted cells and *DNA-PKcs*^*−/−*^ cells showed the same prominent delays in the repair of etoposide-induced DSBs in the G~1~ phase ([Figure 2](#fig2){ref-type="fig"}C), BRCA1\'s contribution to the repair of IR-induced DSBs was less prominent than that of LIG4 ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). We hypothesized that another enzyme(s) substituted for lack of BRCA1 and chose to analyze *BRCA1*^*AID/AID*^*/RNF168*^*−/−*^ TK6 cells because BRCA1 and RNF168 are compensatory in HDR ([@bib97]). Like BRCA1-depleted cells (*BRCA1*^*AID/AID*^ cells treated with auxin), *BRCA1*^*AID/AID*^*/RNF168*^*−/−*^ cells without auxin treatment showed the delayed repair of IR-induced DSBs in the G~1~ phase ([Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}F). The addition of auxin to deplete BRCA1 in the *BRCA1*^*AID/AID*^*/RNF168*^*−/−*^ cells caused a greater delay in the repair of IR-induced DSBs than the BRCA1-depleted *BRCA1*^*AID/AID*^ cells ([Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}F). We also examined the contribution of RNF8, another ubiquitin E3 ligase involved in DSB repair, to the repair of IR-induced DSBs in G~1~-phase cells. We observed the delayed DSB repair in *RNF8*^*−/−*^ cells ([Figures 5](#fig5){ref-type="fig"}E and [S5](#mmc1){ref-type="supplementary-material"}H). The depletion of BRCA1 in *RNF8*^*−/−*^ cells (shBRCA1/*RNF8*^*−/−*^) caused a further delay in the repair of IR-induced DSBs, indicating a compensatory function of BRCA1 and RNF8 in the repair of IR-induced DSBs. Taken together, the data support the idea that removal of blocking adducts from IR-induced DSBs involves more complex ubiquitin signaling than that from etoposide-induced DSBs. RNF8 and RNF168 may mask the important role played by BRCA1 in the repair of IR-induced DSBs in the G~1~ phase.

A Collaboration of ARTEMIS, EXD2, and EXO1 with MRE11 in the Repair of IR-Induced DSBs {#sec2.10}
--------------------------------------------------------------------------------------

We explored the role played by enzymes that are implicated in the processing of IR-induced DSBs in TK6 cells. We analyzed DNA polymerases β and θ, both of which have 5' -deoxyribose phosphate (dRP) lyase activity ([@bib66]), TDP1, TDP2, PARP1, and XRCC1, the last two playing a key role in microhomology-mediated end joining (MMEJ) ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7D) ([@bib72]) ([@bib76]). TK6 cells deficient in these proteins were all tolerant to IR ([Figure S7](#mmc1){ref-type="supplementary-material"}E). We also analyzed nucleases that process DSB ends during the G~1~ phase, including ARTEMIS, EXD2, and EXO1 ([Figures S7](#mmc1){ref-type="supplementary-material"}F--S7H) ([@bib10]). TK6 cells null-deficient in any of these three nucleases were all sensitive to IR ([Figure S7](#mmc1){ref-type="supplementary-material"}E), but the phenotypes were milder than those of LIG4-deficient and MRE11 nuclease-deficient cells ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}D). ARTEMIS has an overhang endonucleolytic processing activity ([@bib48], [@bib62]) and might remove blocking adducts attached to overhang sequences at DSBs. Neither EXD2 nor EXO1 may be able to remove blocking adducts from IR-induced DSBs. It is more likely that these two nucleases generate ligatable blunt-end and cohesive-end breaks ([@bib62]). In summary, these data indicate MRE11 nuclease plays a dominant role in the removal of blocking adducts to generate clean ends and ARTEMIS, EXD2, and EXO1 may subsequently process the clean DSBs for direct ligation by NHEJ.

Discussion {#sec3}
==========

We herein demonstrate that UBC13-mediated ubiquitin signaling plays a pivotal role in the removal of 5′ TOP2 adducts preceding NHEJ ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [4](#fig4){ref-type="fig"}). This signaling is carried out most likely by RAP80 and BRCA1 and activates the MRE11 nuclease to remove 5′ TOP2 adducts. We also show that UBC13-mediated ubiquitin signaling and MRE11 are dispensable for rejoining of the *Asi*SI RE-induced DSBs ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A) but required for most NHEJ-dependent repair events in IR-irradiated G~1~ cells ([Figures 5](#fig5){ref-type="fig"}B, 5C, [S5](#mmc1){ref-type="supplementary-material"}D, and [S6](#mmc1){ref-type="supplementary-material"}D). This finding indicates the crucial role played by both UBC13-mediated ubiquitin signaling and MRE11 in removing IR-induced blocking adducts in addition to TOP2 adducts from DSB ends. NHEJ repairs approximately 80% of the IR-induced DSBs even in the S/G~2~ phases ([@bib9]) ([@bib78]) and plays a more important role in repairing etoposide-induced DSBs than does HDR ([@bib49]). Moreover, the repair time of dirty DSBs induced by etoposide ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}A, and 2C) and IR ([Figures 5](#fig5){ref-type="fig"}B--5E) was several times longer than that of RE-induced clean DSBs ([Figure 5](#fig5){ref-type="fig"}A). Considering these data, the current study sheds light on the removal of blocking adducts from dirty DSBs as the key rate-limiting step in the repair of DSBs generated by radiotherapy and a chemotherapy via etoposide during all phases of the cell cycle.

We have shown that MRE11 plays a dominant role in the removal of blocking adducts prior to NHEJ of clean DSBs in cells. Our results are supported by several biochemical studies that showed that non-covalent DNA-bound KU70/80 proteins stimulate the endonuclease activity of MRE11, leading to the removal of adducts from both 3′ and 5′ termini at DSBs ([@bib21]) ([@bib22]) ([@bib2]) (reviewed in [@bib63]). Thus, MRE11-dependent elimination of various chemical adducts attached to DSB ends may be a common mechanism for generating ligatable clean ends prior to direct ligation by canonical NHEJ. We also examined the contributions of other nucleases to the processing of dirty DSBs in the G~1~ phase. ARTEMIS, EXD2, EXO1, and MRE11 contribute to approximately 36%, 39%, 45%, and 69%, respectively, of the NHEJ events during 6-h repair time post-IR in the G~1~ phase ([Figure 5](#fig5){ref-type="fig"}B). Although exonucleases EXD2 or EXO1 may not be capable of removing various blocking adducts from DSB ends, the loss of ARTEMIS increases sensitivity to camptothecin, a TOP1 poison, but not etoposide ([@bib49]), suggesting that ARTEMIS removes various 3′ blocking adducts including TOP1 adducts from DSBs. ARTEMIS, EXD2, and EXO1 might generate blunt-end and cohesive-end breaks, which can be ligated by LIG4 after the removal of blocking adducts from DSB ends by MRE11. This notion is supported by the previous findings that DSB resection is executed by these nucleases in G~1~ phase ([@bib10]). Identifying the roles played by ARTEMIS, EXD2, and EXO1 in the repair of IR-induced DSBs is an important area of study for the future. In contrast with the four nucleases, DNA polymerases β and θ, both of which have 5′-dRP lyase activity, TDP1, and TDP2 contribute only a little to the repair of IR-induced DSBs ([Figure S7](#mmc1){ref-type="supplementary-material"}E). PARP1 and XRCC1, which play a key role in microhomology-mediated end joining (MMEJ) ([@bib76]) are dispensable for the repair of IR-induced DSBs ([Figure S7](#mmc1){ref-type="supplementary-material"}E), as previously reported ([@bib80]). In conclusion, ARTEMIS, EXD2, EXO1, and MRE11 all contribute to the repair of IR-induced DSBs in preparation for subsequent NHEJ. Given the dominant role played by MRE11, ARTEMIS, EXD2, and EXO1 may collaborate with MRE11 in the repair of IR-induced DSBs.

To protect genomic DNA from excess degradation, nuclease activity is strictly regulated ([@bib83]). The mechanisms underlying MRE11 nuclease activity in the S/G~2~ phases have been thoroughly studied, but it is unclear how MRE11 nuclease is regulated in the removal of chemical adducts from DSB ends during the G~1~ phase. MRE11 nuclease activity is regulated by phosphorylation during DSB resection in the S/G~2~ phases ([@bib17]) ([@bib27]) ([@bib42]). DSB resection is also promoted by UBC13-dependent ubiquitination of histones at DSB sites (reviewed in [@bib85]), although the usage of the lysine residues on the ubiquitin is unclear. In the present study, we show that UBC13-mediated ubiquitination signaling is activated not only during the S/G~2~ phases but also during the G~1~ phase ([Figure 1](#fig1){ref-type="fig"}). Activation of ubiquitin signaling in the G~1~ phase is required for the physical interaction between BRCA1 and MRE11 ([Figure 4](#fig4){ref-type="fig"}B), similar to S/G~2~ phases ([@bib95]). The resulting BRCA1-MRE11 complex that forms at the DSB site is essential for the removal of etoposide-induced 5′ TOP2 adducts. In addition to ubiquitin signaling-dependent BRCA1-MRE11 complex formation, CtIP, a regulatory factor of DSB end resection, also plays a critical role in the removal of blocking adducts. Biochemical studies demonstrated that phosphorylated CtIP stimulates MRE11 nuclease activity for the removal of blocking adducts ([@bib2], [@bib3], [@bib67]). CDK-dependent phosphorylation in CtIP is required for the removal of 5′ TOP2 adducts by promoting the interaction between CtIP and BRCA1 ([@bib4], [@bib56]). The phosphorylated CtIP is recognized by NBS1, which regulates the nuclease activity of MRE11-RAD50 complex ([@bib2], [@bib21]). It is possible that phosphorylated CtIP regulates MRE11 nuclease activity by facilitating complex formation among BRCA1-MRN-CtIP at etoposide-induced DSB sites in G~1~ phase. BRCA1 also promotes the removal of IR-induced chemical adducts by MRE11 prior to direct ligation of these processed DSBs by NHEJ. UBC13-mediated ubiquitination seems to activate complex signaling pathways involving multiple proteins, including BRCA1, RNF8, and RNF168 ([Figures 5](#fig5){ref-type="fig"}D and 5E), and contribute to the repair of IR-induced DSBs in the G~1~ phase. In sum, UBC13-mediated ubiquitin signaling activates MRE11-dependent DSB end-processing. Future biochemical studies are needed to clarify how BRCA1 stimulates the endonuclease activity of MRE11.

We propose a model in which dirty DSBs, induced by etoposide and IR, are repaired during the G~1~ phase. DSBs are rapidly recognized by the KU70/80 complex (step 2, [Figures 6](#fig6){ref-type="fig"}A and 6B). It remains unclear whether the KU70/80 complex interacts with DSB ends bearing intact TOP2 or interacts after TOP2 adducts are degraded by proteasome ([@bib37], [@bib46]). TDP2 removes TOP2 adducts after its degradation by the proteasome ([@bib46]). UBC13 catalyzes ubiquitination of histones at DSB sites in collaboration with ubiquitin E3 ligase(s), such as RNF8 and RNF168 (step 3, [Figure 6](#fig6){ref-type="fig"}B). The clean DSB ends induced by RE are quickly rejoined by NHEJ (step 3, [Figure 6](#fig6){ref-type="fig"}A). This ubiquitination (step 3, [Figure 6](#fig6){ref-type="fig"}B) facilitates the recruitment of multiple proteins such as BRCA1 and RAP80 onto the dirty DSB ends (step 4, [Figure 6](#fig6){ref-type="fig"}B). The recruited BRCA1 forms a stable complex with MRE11, with the resulting complex perhaps stimulating the endonuclease activity of MRE11 (step 5, [Figure 6](#fig6){ref-type="fig"}B). It remains unclear how RNF168 promotes the repair of IR-induced DSBs. Non-covalent DNA-bound KU70/80 proteins also stimulate MRE11 endonuclease activity, as previously suggested ([@bib22]) ([@bib69]). This stimulated MRE11 endonuclease engages in sequential endonucleolytic processing of both 5′ and 3′ termini and may completely remove both blocking adducts and KU70/80 proteins from the DSBs (steps 6 and 7, [Figure 6](#fig6){ref-type="fig"}B) ([@bib22]) (reviewed in [@bib63]). The resulting clean DSB ends are bound by KU70/80 proteins (step 9, [Figure 6](#fig6){ref-type="fig"}B), leading to rejoining of the DSBs by canonical NHEJ (step 10, [Figure 6](#fig6){ref-type="fig"}B). The mechanism by which a variety of chemicals adducts at IR-induced DSBs is likely to be much more complicated than that by which 5′ TOP2 adducts are removed, with multiple mechanisms in play, depending on the structure of the dirty DSB ends. Future study will shed light on the multiple mechanisms underlying the removal of a variety of chemical adducts prior to NHEJ.Figure 6Proposed Model for Ten-Step Elimination of the Adducts Attached to DSB Ends(A) Restriction enzyme generates "clean" DSBs with 3′- hydroxyl groups and 5′-phosphate ends (step 1). The DSB ends are rapidly recognized by the KU70/80 complex (step 2) and rejoined by canonical NHEJ (step 3).(B) Ionizing radiation generates "dirty" DSBs associated with 3′ and 5′ adducts (step 1). The DSB ends are rapidly recognized by the KU70/80 complex (step 2). UBC13 promotes K63 ubiquitination at DSB sites (step 3), where this ubiquitination is recognized by the BRCA1-RAP80 complex (step 4). UBC13 and RAP80 are required for stable complex formation between BRCA1 and MRE11 at DSB sites (step 5). Endonucleolytic cleavage by MRE11 releases 5′ and -3′ adducts from the DSB ends (steps 6--8). The resulting clean DSB ends are again recognized by the KU70/80 complex (step 9), then ligated by canonical NHEJ (step 10).

Limitations of the Study {#sec3.1}
------------------------

In this study, we identified the involvement of the UBC13-mediated ubiquitination pathway in the removal of blocking adducts generated not only by etoposide but also by ionizing radiation. Mechanistically, UBC13-mediated ubiquitination signaling strongly promotes the interaction between BRCA1 and MRE11, thereby stimulating nuclease activity of MRE11 for the removal of blocking adducts from DSB sites. The current study has not clearly demonstrated the molecular targets ubiquitinated by UBC13 at the DSB sites. This topic should be investigated in future work.

Methods {#sec5}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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